Coffin-Lowry syndrome: clinical and molecular features
- PMID: 12362025
- PMCID: PMC1734994
- DOI: 10.1136/jmg.39.10.705
Coffin-Lowry syndrome: clinical and molecular features
Abstract
The Coffin-Lowry syndrome (CLS) is a rare X linked disorder in which affected males show severe mental retardation with characteristic dysmorphism, most notably affecting the face and hands. The typical facial features consist of a prominent forehead, hypertelorism, a flat nasal bridge, downward sloping palpebral fissures, and a wide mouth with full lips. Mild progression in facial coarsening occurs during childhood and adult life. The hands are broad with soft, stubby, tapering fingers. Other clinical findings include short stature (95%), a pectus deformity (80%), a kyphosis and/or scoliosis (80%), mitral valve dysfunction, and sensorineural hearing loss. The causal gene, RSK2, was identified in 1996 and contains 22 exons which encode a protein of 740 amino acids. Over 75 distinct pathogenic mutations have been identified in 250 unrelated CLS patients.
Similar articles
-
A syndromic form of X-linked mental retardation: the Coffin-Lowry syndrome.Eur J Pediatr. 2002 Apr;161(4):179-87. doi: 10.1007/s00431-001-0904-6. Eur J Pediatr. 2002. PMID: 12014383 Review.
-
Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.Am J Hum Genet. 1998 Dec;63(6):1631-40. doi: 10.1086/302153. Am J Hum Genet. 1998. PMID: 9837815 Free PMC article.
-
Unreported RSK2 missense mutation in two male sibs with an unusually mild form of Coffin-Lowry syndrome.J Med Genet. 1999 Oct;36(10):775-8. doi: 10.1136/jmg.36.10.775. J Med Genet. 1999. PMID: 10528858 Free PMC article.
-
A newborn diagnosed with van Maldergem syndrome.Clin Dysmorphol. 2018 Apr;27(2):63-65. doi: 10.1097/MCD.0000000000000211. Clin Dysmorphol. 2018. PMID: 29505454 No abstract available.
-
Schinzel-Giedion syndrome: a novel case, review and revised diagnostic criteria.J Genet. 2018 Mar;97(1):35-46. J Genet. 2018. PMID: 29666323 Review.
Cited by
-
Stimulus-induced myoclonus treated effectively with clonazepam in genetically confirmed Coffin-Lowry syndrome.Epilepsy Behav Case Rep. 2014 Nov 25;2:196-8. doi: 10.1016/j.ebcr.2014.09.007. eCollection 2014. Epilepsy Behav Case Rep. 2014. PMID: 25667906 Free PMC article.
-
Mitral and tricuspid valve surgery for Coffin-Lowry syndrome.Gen Thorac Cardiovasc Surg. 2015 May;63(5):290-2. doi: 10.1007/s11748-013-0291-8. Epub 2013 Jul 20. Gen Thorac Cardiovasc Surg. 2015. PMID: 23873216
-
Therapeutic targeting of p90 ribosomal S6 kinase.Front Cell Dev Biol. 2023 Dec 19;11:1297292. doi: 10.3389/fcell.2023.1297292. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38169775 Free PMC article. Review.
-
The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient.Hum Genet. 2007 Dec;122(5):541-3. doi: 10.1007/s00439-007-0424-1. Epub 2007 Aug 24. Hum Genet. 2007. PMID: 17717706
-
Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling.J Biol Chem. 2009 Feb 27;284(9):5557-73. doi: 10.1074/jbc.M805705200. Epub 2008 Dec 22. J Biol Chem. 2009. PMID: 19103592 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical